UNITAID is an international drug purchase facility, established to provide long-term, sustainable and predictable funding to increase access and reduce prices of quality drugs and diagnostics for the treatment of HIV/AIDS, malaria and tuberculosis in developing countries.
The Board approved four new Projects for a total amount of over 182 million dollars. These include:
- To provide 20 million Insecticide-treated Nets.
- To accelerate the implementation of comprehensive Prevention of Mother-to-Child Transmission (PMTCT) services in the area of access to HIV care and treatment in nine countries.
- To promote and safeguard the availability of ARV treatment and its good management for people living with HIV/AIDS.
- To facilitate procurement and increase access to quality diagnostics for initiating and monitoring treatment of HIV/AIDS and malaria.
>> More information
News
Cyprus' decision to participate in UNITAID
15 September 2008
UNITAID welcomes the announcement by the Government of the Republic of Cyprus in late July to inject significant new resources into the global effort to test and treat people suffering from HIV/AIDS, malaria and tuberculosis. Cyprus has committed an annual contribution of EURO 400 000 to UNITAID for the six coming years to purchase diagnostics and medicines for the three priority diseases in the countries that need them most.
Read more...
UNITAID, UNICEF and WHO announce massive scale-up in fight against HIV in mothers and children
30 August 2008Read more...
UNITAID moves towards a patent pool for medicines
9 July 2008UNITAID's Executive Board approved the principle of establishing a patent pool for medicines during its eighth session in Geneva, 2-3 July 2008. This initiative aims to provide patients in low and middle income countries with increased access to more appropriate and affordable medicines.
Read more...
New rapid tests for drug-resistant TB for developing countries
30 June 2008People in low-resource countries who are ill with multidrug-resistant TB (MDR-TB) will get a faster diagnosis -- in two days, not the standard two to three months -- and appropriate treatment thanks to two new initiatives unveiled today by WHO, the Stop TB Partnership, UNITAID and the Foundation for Innovative New Diagnostics (FIND).
Read more...